Author

Liyang Du

Observed name: Du, Liyang

Institution: Putian University

Observed institutions: Putian University, Fuzhou University

ORCID: 0000-0003-3873-4387

Observed ORCID: 0000-0003-3873-4387

OpenAlex ID: A5080485988

A Hypoxia-Activated Prodrug Conjugated with a BODIPY-Based Photothermal Agent for Imaging-Guided Chemo-Photothermal Combination Therapy

2022 · De-Chao Yang, Lin-Feng Wen, et al. · ACS Applied Materials & Interfaces · 45

Discovery of a novel Aurora B inhibitor GSK650394 with potent anticancer and anti- aspergillus fumigatus dual efficacies in vitro

2021 · Yuhua He, Wei Fu, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 16

Molecular mechanism of allosteric activation of the CRISPR ribonuclease Csm6 by cyclic tetra-adenylate

2023 · Liyang Du, Qinwei Zhu, et al. · The EMBO Journal · 13

Hypoxia-Responsive Nano-Photosensitizer Anchored by PEGylated BODIPY: A Single-Laser-Driven Platform for Photo-Enhanced Synergistic Chemo/Photodynamic/Photothermal Cancer Therapy

2025 · De-Chao Yang, Huamei Zhuang, et al. · Molecular Pharmaceutics · 11

Molecular basis of stepwise cyclic tetra-adenylate cleavage by the type III CRISPR ring nuclease Crn1/Sso2081

2023 · Liyang Du, Danping Zhang, et al. · Nucleic Acids Research · 10

Walrycin B, as a novel separase inhibitor, exerts potent anticancer efficacy in a mouse xenograft model

2024 · Qinwei Zhu, Liyang Du, et al. · Biochemical Pharmacology · 3

Structural insight into the Csx1–Crn2 fusion self-limiting ribonuclease of type III CRISPR system

2024 · Danping Zhang, Liyang Du, et al. · Nucleic Acids Research · 3

Formulation development and optimization of sparfloxacin-loaded solid lipid nanoparticles integrated with microneedles for the treatment of biofilm-infected wounds

2026 · Jianmin Chen, Wanhui Wu, et al. · European Journal of Pharmaceutics and Biopharmaceutics

Works count: 9

Citation count: 101

H-index: 5

I10-index: 5